A future beyond
Type 1 Diabetes

We champion bold research and visionary scientists to get closer to a world where Type 1 Diabetes is no longer a daily burden.


Our beneficiaries


Progress today cure tomorrow


At the Bukhman Foundation, one of our core missions is to find a cure for people with Type 1 Diabetes (T1D). We believe that bold ideas and visionary leadership can get us there. By partnering with researchers who push boundaries and challenge conventional thinking, we aim to build a future where T1D no longer limits how people live, dream, and thrive.


Our approach to funding medical research is grounded in partnership, trust, and long-term ambition. We support cutting-edge science, promote open research, and encourage collaboration between leading experts and institutions across the globe.


Our pledge

£100m to transform lives


The Bukhman Foundation is pledging the UK’s largest philanthropic commitment to funding groundbreaking research into treatments and cures for Type 1 Diabetes.



What we’re supporting

The Bukhman Centre for Research Excellence in Type 1 Diabetes

Catalysing breakthroughs at Oxford to cure Type 1 Diabetes.

2025Status: Active

Project highlights

See all
Type 1 Diabetes 14 April 2026

Bukhman Foundation backs James Norton’s TCS London Marathon run for Breakthrough T1D

All donations will be double-matched to support type 1 diabetes research.

Type 1 diabetesBreakthrough T1D
Type 1 Diabetes 9 April 2026

Anastasia Bukhman appointed to the T1D Fund Board of Directors

Her appointment underscores a shared commitment to advancing innovative therapies for type 1 diabetes.

Type 1 DiabetesT1D Fund
Type 1 Diabetes 28 January 2026

Rufus: A Friend for Children with Type 1 Diabetes

A new initiative, in collaboration with Breakthrough T1D UK, refreshes Rufus and expands support for children and families living with T1D.

Type 1 DiabetesBreakthrough T1D

Who we partner with


We partner with leading researchers and institutions globally, supporting innovative, expert-led research that pushes scientific boundaries and aims for transformational impact. Our partners include University of Oxford, Cambridge University, Harvard University, Breakthrough T1D, T1D Fund and Diabetes UK.